Bio-Rad (NYSE:BIO) to Announce Fourth Quarter and Full Year 2025 Financial Results

January 29, 2026 — Leads & Copy — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) will release its financial results for the fourth quarter and full year 2025 on Thursday, February 12, 2026, after the market closes.

Management will hold a conference call at 2:00 PM Pacific Time (5:00 PM Eastern Time) on the same day to discuss the results. Participants within the U.S. can dial (800) 715-9871, while those outside the U.S. can dial (646) 307-1963, using access code 9562470.

A live webcast of the conference call, accompanied by a supplemental earnings presentation, will be accessible in the “Investor Relations” section of Bio-Rad’s website under “Events & Presentations” at investors.bio-rad.com. The webcast replay will be available for one year.

Bio-Rad Laboratories, Inc. is based in Hercules, California. The company operates a global network of research, development, manufacturing, and sales operations, employing approximately 7,500 individuals. Bio-Rad reported $2.6 billion in revenues in 2024.

Bio-Rad develops, manufactures, and markets products for the life science research and clinical diagnostics markets. Its customer base includes universities, research institutions, hospitals, biopharmaceutical companies, and clinical, food safety and environmental quality laboratories.

Together, Bio-Rad develops products to advance science and save lives.

Source: Bio-Rad

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.